These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1256 related items for PubMed ID: 12858154

  • 1. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P, Atzeni F, Carrabba M.
    Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
    [Abstract] [Full Text] [Related]

  • 2. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [Abstract] [Full Text] [Related]

  • 3. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J, Ames PR, Donohue S, Stanyer L, Nourooz-Zadeh J, Ravirajan C, Isenberg DA.
    Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928
    [Abstract] [Full Text] [Related]

  • 4. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
    Brenner B, Tavori S, Lerner M, Tatarsky I, Lorber M.
    Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
    [Abstract] [Full Text] [Related]

  • 5. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J, Kumar S, Isenberg DA.
    Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
    [Abstract] [Full Text] [Related]

  • 6. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [Abstract] [Full Text] [Related]

  • 7. [Antiphospholipid syndrome and stroke].
    Kitagawa Y.
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [Abstract] [Full Text] [Related]

  • 8. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
    Tarr T, Lakos G, Bhattoa HP, Szegedi G, Shoenfeld Y, Kiss E.
    Lupus; 2007 Nov; 16(5):324-8. PubMed ID: 17576733
    [Abstract] [Full Text] [Related]

  • 9. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

  • 10. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
    Salazar-Páramo M, Jara LJ, Ramos A, Barile L, Machado G, García-De La Torre I.
    Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
    [Abstract] [Full Text] [Related]

  • 11. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.
    Somers E, Magder LS, Petri M.
    J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
    Muñoz-Rodríguez FJ, Reverter JC, Font J, Tàssies D, Cervera R, Espinosa G, Carmona F, Balasch J, Ordinas A, Ingelmo M.
    Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
    [Abstract] [Full Text] [Related]

  • 13. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome].
    Swadźba J, Musiał J, Jankowski M, Grzywacz M, Szczeklik A.
    Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202
    [Abstract] [Full Text] [Related]

  • 14. Cardiac manifestations in antiphospholipid syndrome.
    Soltész P, Szekanecz Z, Kiss E, Shoenfeld Y.
    Autoimmun Rev; 2007 Jun; 6(6):379-86. PubMed ID: 17537384
    [Abstract] [Full Text] [Related]

  • 15. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E.
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [Abstract] [Full Text] [Related]

  • 16. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A, Kickler TS, Petri M.
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [Abstract] [Full Text] [Related]

  • 17. Antiphospholipid syndrome.
    Gezer S.
    Dis Mon; 2003 Dec; 49(12):696-741. PubMed ID: 14679358
    [Abstract] [Full Text] [Related]

  • 18. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
    Bruce IN.
    Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
    [Abstract] [Full Text] [Related]

  • 19. [Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome].
    Reshetniak TM, Boĭtsekhovskaia B, Alekberova ZS, Kalashnikova LA, Mach ES, Zabek Ia.
    Klin Med (Mosk); 1999 Dec; 77(5):32-7. PubMed ID: 10394784
    [Abstract] [Full Text] [Related]

  • 20. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
    Soltész P, Veres K, Kiss E, Lakos G, Sonkoly I, Muszbek L, Szegedi G.
    Orv Hetil; 2000 Dec 24; 141(52):2821-5. PubMed ID: 11202118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.